HENRY M. FARIS JR., M.D.; DAVID W. POTTS, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In a clinical evaluation of azlocillin, we administered 21 courses of therapy to 16 adult patients with Pseudomonas aeruginosa infections between June and November 1982. The incidental finding of relative hypouricemia during azlocillin treatment prompts us to document this previously unreported observation.
The average serum uric acid level before treatment was 5.47 mg/dL. The average level during treatment was 3.15 mg/dL, with most determinations being done on the fourth or fifth day. Treatment courses ranged from 5 to 28 days. Eighteen courses were associated with decreases in uric acid during treatment (average decrease, 3.0 mg/dL), two with
FARIS HM, POTTS DW. Azlocillin and Serum Uric Acid. Ann Intern Med. ;98:414. doi: 10.7326/0003-4819-98-3-414_3
Download citation file:
Published: Ann Intern Med. 1983;98(3):414.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use